Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio - Chinot, Olivier L.; Wick, Wolfgang (Neuro-Oncology, 2016)
Gesehen am 07.02.2018